Reduced oxidative stress contributes to the lipid lowering effects of isoquercitrin in free fatty acids induced hepatocytes

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Hassan, Waseem ^a   Rongyin, Gao ^a   Daoud, Abdelkader ^a   Ding, Lin ^a   Wang, Lulu ^a   Liu, Jun ^a   Shang, Jing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER; METABOLISM; OXIDATIVE STRESS; OXYGEN; PHYSIOLOGY; SELF ASSEMBLY;

ANTI OXIDATIVE ACTIVITY; FREE FATTY ACID; LIPID METABOLISMS; LIPID-LOWERING EFFECTS; MOLECULAR LEVELS; PRO-INFLAMMATORY CYTOKINES; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASES;

FATTY ACIDS;

3,4 METHYLENEDIOXYAMPHETAMINE; ACETYLCYSTEINE; CYTOKINE; FATTY ACID; ISOQUERCITRIN; MALONALDEHYDE; METHAMPHETAMINE; REACTIVE OXYGEN METABOLITE; SIMVASTATIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; LIPOPOLYSACCHARIDE; OLEIC ACID; PALMITIC ACID DERIVATIVE; QUERCETIN;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; CELLS; CONTROLLED STUDY; INTELLIGENCE QUOTIENT; KUPFFER CELL; LIPID LIVER LEVEL; LIPID STORAGE; LIVER CELL; NONHUMAN; OXIDATIVE STRESS; RAT; ANALOGS AND DERIVATIVES; ANIMAL; CELL LINE; CELL SURVIVAL; COCULTURE; CYTOLOGY; DRUG EFFECTS; LIPID METABOLISM; LIVER; METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CELL LINE; CELL SURVIVAL; COCULTURE TECHNIQUES; HEPATOCYTES; KUPFFER CELLS; LIPID METABOLISM; LIPOPOLYSACCHARIDES; LIVER; OLEIC ACID; OXIDATIVE STRESS; PALMITATES; QUERCETIN; RATS; REACTIVE OXYGEN SPECIES; TRIGLYCERIDES;

EID: 84911365992     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/313602     Document Type: Article

References (48)

1. Day C. P., Pathogenesis of steatohepatitis. Bailliere's Best Practice and Research in Clinical Gastroenterology 2002 16 5 663 678 10.1053/bega.2002.0333 2-s2.0-0036780582
2. Lanaspa M. A., Sanchez-Lozada L. G., Choi Y., Cicerchi C., Kanbay M., Roncal-Jimenez C. A., Ishimoto T., Li N., Marek G., Duranay M., Schreiner G., Rodriguez-Iturbe B., Nakagawa T., Kang D., Sautin Y. Y., Johnson R. J., Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. The Journal of Biological Chemistry 2012 287 48 40732 40744 10.1074/jbc.M112.399899 2-s2.0-84869996114
3. Espinosa A., Prevention of liver steatosis through fish oil supplementation: correlation of oxidative stress with insulin resistance and liver fatty acid content. Archivos Latinoamericanos de Nutrición 2013 63 1 29 36
4. Sivaraman K., Senthilkumar G. P., Sankar P., Bobby Z., Attenuation of oxidative stress, inflammation and insulin resistance by allium sativum in fructose-fed male rats. Journal of Clinical and Diagnostic Research 1860 7 9 1860 1862 10.7860/JCDR/2013/6924.3334
5. Wang B., Sun J., Li X., Zhou Q., Bai J., Shi Y., Le G., Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity. Nutrition Research 2013 33 11 971 981 10.1016/j.nutres.2013.07.016 2-s2.0-84882740979
6. Wheeler M. D., Kono H., Yin M., Nakagami M., Uesugi T., Arteel G. E., Gäbele E., Rusyn I., Yamashina S., Froh M., Adachi Y., Iimuro Y., Bradford B. U., Smutney O. M., Connor H. D., Mason R. P., Goyert S. M., Peters J. M., Gonzalez F. J., Samulski R. J., Thurman R. G., The role of kupffer cell oxidant production in early ethanol-induced liver disease. Free Radical Biology & Medicine 2001 31 12 1544 1549 10.1016/S0891-5849(01)00748-1 2-s2.0-0035893937
7. Kogiso T., Moriyoshi Y., Nagahara H., Clinical significance of fatty liver associated with metabolic syndrome. Hepatology Research 2007 37 9 711 721 10.1111/j.1872-034X.2007.00116.x 2-s2.0-34447302825
8. Gastaldelli A., Kozakova M., Højlund K., Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009 49 5 1537 1544 10.1002/hep.22845
9. do Nascimento J. H., Epifanio M., Soder R. B., Baldisserotto M., MRI-diagnosed nonalcoholic fatty liver disease is correlated to insulin resistance in adolescents. Academic Radiology 2013 20 11 1436 1442
10. Liao C. C., Ou T. T., Wu C. H., Wang C. J., Prevention of diet-induced hyperlipidemia and obesity by caffeic acid in C57BL/6 mice through regulation of hepatic lipogenesis gene expression. Journal of Agricultural and Food Chemistry 2013 61 46 11082 11088 10.1021/jf4026647
11. Chen H., Adiponectin activates the AMPK signaling pathway to regulate lipid metabolism in bovine hepatocytes. The Journal of Steroid Biochemistry and Molecular Biology 2013 138 445 454
12. Enjoji M., Yasutake K., Kohjima M., Nakamuta M., Nutrition and nonalcoholic fatty liver disease: the significance of cholesterol. International Journal of Hepatology 2012 2012 6 925807 10.1155/2012/925807
13. Ruderman N., Prentki M., AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nature Reviews Drug Discovery 2004 3 4 340 351 10.1038/nrd1344 2-s2.0-3843061592
14. Granica S., Czerwińska M. E., Zyzyńska-Granica B., Kiss A. K., Antioxidant and anti-inflammatory flavonol glucuronides from Polygonum aviculare L. Fitoterapia 2013 91 180 188
15. Chirumbolo S., The role of quercetin, flavonols and flavones in modulating inflammatory cell function. Inflammation and Allergy-Drug Targets 2010 9 4 263 285 10.2174/187152810793358741 2-s2.0-79751471302
16. Benmalek Y., Yahia O. A., Belkebir A., Fardeau M., Anti-microbial and anti-oxidant activities of illicium verum, Crataegus oxyacantha ssp monogyna and Allium cepa red and white varieties. Bioengineered 2013 4 4 244 248 10.4161/bioe.24435 2-s2.0-84883256115
17. Liu H. L., Jiang W. B., Xie M. X., Flavonoids: Recent advances as anticancer drugs. Recent Patents on Anti-Cancer Drug Discovery 2010 5 2 152 164 2-s2.0-77952959798
18. Vidyalakshmi K., Kamalakannan P., Viswanathan S., Ramaswamy S., Anti-inflammatory effect of certain dihydroxy flavones and the mechanisms involved. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2012 11 3 253 261 10.2174/1871523011202030253 2-s2.0-84877776283
19. Li R., Yuan C., Dong C., Shuang S., Choi M. M. F., In vivo antioxidative effect of isoquercitrin on cadmium-induced oxidative damage to mouse liver and kidney. Naunyn-Schmiedeberg's Archives of Pharmacology 2011 383 5 437 445 10.1007/s00210-011-0613-2 2-s2.0-79955699097
20. Jung S. H., Kim B. J., Lee E. H., Osborne N. N., Isoquercitrin is the most effective antioxidant in the plant Thuja orientalis and able to counteract oxidative-induced damage to a transformed cell line (RGC-5 cells). Neurochemistry International 2010 57 7 713 721 10.1016/j.neuint.2010.08.005 2-s2.0-77958086270
21. Boots A. W., Drent M., de Boer V. C. J., Bast A., Haenen G. R. M. M., Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis. Clinical Nutrition 2011 30 4 506 512 10.1016/j.clnu.2011.01.010 2-s2.0-79960691818
22. Hoek-van den Hil E. F., Keijer J., Bunschoten A., Vervoort J. J. M., Stankova B., Bekkenkamp M., Herreman L., Venema D., Hollman P. C. H., Tvrzicka E., Rietjens I. M. C. M., van Schothorst E. M., Quercetin induces hepatic lipid omega-oxidation and lowers serum lipid levels in mice. PLoS ONE 2013 8 1 e51588 10.1371/journal.pone.0051588 2-s2.0-84872837874
23. Guo X. D., Zhang D., Gao X., Parry J., Liu K., Liu B., Wang M., Quercetin and quercetin-3-O-glucuronide are equally effective in ameliorating endothelial insulin resistance through inhibition of reactive oxygen species-associated inflammation. Molecular Nutrition and Food Research 2013 57 6 1037 1045 10.1002/mnfr.201200569 2-s2.0-84878926920
24. Lee S. H., Kim B., Oh M. J., Yoon J., Kim H. Y., Lee K. J., Lee J. D., Choi K., Persicaria hydropiper (L.) spach and its flavonoid components, isoquercitrin and isorhamnetin, activate the Wnt/- β catenin pathway and inhibit adipocyte differentiation of 3T3-L1 cells. Phytotherapy Research 2011 25 11 1629 1635 10.1002/ptr.3469 2-s2.0-80054944137
25. Karaskov E., Scott C., Zhang L., Teodoro T., Ravazzola M., Volchuk A., Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic β -cell apoptosis. Endocrinology 2006 147 7 3398 3407 10.1210/en.2005-1494 2-s2.0-33745116619
26. Akazawa Y., Cazanave S., Mott J. L., Elmi N., Bronk S. F., Kohno S., Charlton M. R., Gores G. J., Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis. Journal of Hepatology 2010 52 4 586 593 10.1016/j.jhep.2010.01.003 2-s2.0-77949655879
27. Hong E. J., Levasseur M.-P., Dufour C. R., Perry M.-C., Giguere V., Loss of estrogen-related receptor alpha promotes hepatocarcinogenesis development via metabolic and inflammatory disturbances. Proceedings of the National Academy of Sciences of the United States of America 2013 110 44 17975 17980
28. Chavez-Tapia N. C., Rosso N., Tiribelli C., Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease. BMC Gastroenterology 2012 12, article 20 10.1186/1471-230X-12-20 2-s2.0-84857539784
29. Cui W., Chen S. L., Hu K., Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. American Journal of Translational Research 2010 2 1 95 104 2-s2.0-77953391746
30. Bustin S. A., Benes V., Garson J. A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M. W., Shipley G. L., Vandesompele J., Wittwer C. T., The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry 2009 55 4 611 622 10.1373/clinchem.2008.112797 2-s2.0-64149097786
31. China Pharmacopoeia Committee, Pharmacopoeia of the People's Republic of China 2010 Beijing, China Chinese Medicine and Technology Publishing House The First Division of 2010 Edition
32. Motoyama K., Koyama H., Moriwaki M., Emura K., Okuyama S., Sato E., Inoue M., Shioi A., Nishizawa Y., Atheroprotective and plaque-stabilizing effects of enzymatically modified isoquercitrin in atherogenic apoE-deficient mice. Nutrition 2009 25 4 421 427 10.1016/j.nut.2008.08.013 2-s2.0-60749114718
33. Lee S., Park H., Notsu Y., Ban H. S., Kim Y. P., Ishihara K., Hirasawa N., Jung S. H., Lee Y. S., Lim S. S., Park E., Shin K. H., Seyama T., Hong J., Ohuchi K., Effects of hyperin, isoquercitrin and quercetin on lipopolysaccharide- induced nitrite production in rat peritoneal macrophages. Phytotherapy Research 2008 22 11 1552 1556 10.1002/ptr.2529 2-s2.0-57349117995
34. Ekstedt M., Franzén L. E., Mathiesen U. L., Holmqvist M., Bodemar G., Kechagias S., Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study. Journal of Hepatology 2007 47 1 135 141 10.1016/j.jhep.2007.02.013 2-s2.0-34249342305
35. Xiao J., Guo R., Fung M. L., Liong E. C., Tipoe G. L., Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges. Hepatobiliary and Pancreatic Diseases International 2013 12 2 125 135 10.1016/S1499-3872(13)60021-1 2-s2.0-84879273144
36. Ábel T., Fehér J., Dinya E., Eldin M. G., Kovács A., Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease. Medical Science Monitor 2009 15 12 MS6 MS11 2-s2.0-75149137084
37. Loria P., Lonardo A., Anania F., Liver and diabetes. A vicious circle. Hepatology Research 2013 43 1 51 64 10.1111/j.1872-034X.2012.01031.x 2-s2.0-84872671526
38. Sugimoto K., Takei Y., Clinicopathological features of non-alcoholic fatty liver disease. Hepatology Research 2011 41 10 911 920 10.1111/j.1872-034X.2011.00867.x 2-s2.0-80053244654
39. Garcia M. C., Amankwa-Sakyi M., Flynn T. J., Cellular glutathione in fatty liver in vitro models. Toxicology in Vitro 2011 25 7 1501 1506 10.1016/j.tiv.2011.05.011 2-s2.0-84860389874
40. Brumbaugh D. E., Friedman J. E., Developmental origins of nonalcoholic fatty liver disease. Pediatric Research 2014 75 1-2 140 147
41. Huc L., Lemarié A., Guéraud F., Héliès-Toussaint C., Low concentrations of bisphenol A induce lipid accumulation mediated by the production of reactive oxygen species in the mitochondria of HepG2 cells. Toxicology in Vitro 2012 26 5 709 717 10.1016/j.tiv.2012.03.017 2-s2.0-84861526983
42. Fusai G., Glantzounis G. K., Hafez T., Yang W., Quaglia A., Sheth H., Kanoria S., Parkes H., Seifalian A., Davidson B. R., N -acetylcysteine ameliorates the late phase of liver ischaemia/reperfusion injury in the rabbit with hepatic steatosis. Clinical Science 2005 109 5 465 473 10.1042/CS20050081 2-s2.0-27844514137
43. Samuhasaneeto S., Thong-Ngam D., Kulaputana O., Patumraj S., Klaikeaw N., Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis. Journal of the Medical Association of Thailand 2007 90 4 788 797 2-s2.0-34948869977
44. Baumgardner J. N., Shankar K., Hennings L., Albano E., Badger T. M., Ronis M. J. J., N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis. Journal of Nutrition 2008 138 10 1872 1879 2-s2.0-54749129969
45. Shirwany N. A., Zou M., AMPK in cardiovascular health and disease. Acta Pharmacologica Sinica 2010 31 9 1075 1084 10.1038/aps.2010.139 2-s2.0-77956390352
46. Huang W., Metlakunta A., Dedousis N., Zhang P., Sipula I., Dube J. J., Scott D. K., O'Doherty R. M., Depletion of liver kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 2010 59 2 347 357 10.2337/db09-0016 2-s2.0-77449117735
47. Hassan W., Ding L., Gao R. Y., Liu J., Shang J., Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders. Cytokine 2014 66 2 133 142
48. Nov O., Shapiro H., Ovadia H., Tarnovscki T., Dvir I., Shemesh E., Kovsan J., Shelef I., Carmi Y., Voronov E., Apte R. N., Lewis E., Haim Y., Konrad D., Bashan N., Rudich A., Interleukin-1 β regulates fat-liver crosstalk in obesity by auto- paracrine modulation of adipose tissue inflammation and expandability. PLoS ONE 2013 8 1 e53626 10.1371/journal.pone.0053626 2-s2.0-84872480987